The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01960712

Enrollment

Registered

2013-10-11

Start date

2008-11-30

Completion date

2017-05-31

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Leakage

Brief summary

Bile leakage after liver transection is treated by external drainage. The question addressed is whether downstream control by transpapillary stent insertion into distal bile duct can enhance healing.

Detailed description

All patients who present with clinically significant bile leakage after liver resection at postoperative day two or longer are offered the opportunity to become randomized to either continuous external drainage or the addition of transpapillary stent.

Interventions

DEVICETranspapillary plastic stent (7-10 Fr)

Duodenoscopy plus transpapillary bile cannulation plus stent insertion.

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Liver resection including at least two liver segments.

Exclusion criteria

* Hepatobiliary digestive anastomosis.

Design outcomes

Primary

Measure	Time frame
Number of days of bile leakage from the abdominal cavity	From intervention until day discharge from hospital

Secondary

Measure	Time frame
General complications rates. Postoperative hospital stay	From intervention until day of discharge from hospital

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026